News Headlines Article

Could one-two punch of generics for breast cancer be more powerful than wonder drug tamoxifen?
Washington Post

First marketed in the 1960s as a fertility drug, tamoxifen has been hailed as a miracle drug for its ability to prevent and treat breast cancer, and despite decades of research scientists have not been able to find anything comparable — until now.

In a study published in The Lancet on Thursday, researchers found that a class of inexpensive, existing generic called aromatase inhibitors, which suppress hormones, reduce recurrence rates by 30 percent as compared with tamoxifen.  That confirmed what researchers had believed for several years. But a separate finding about the effect of the drug on death risk was a surprise.